625-69-4

Usage

Uses

Used in Chemical Synthesis:
2,4-Pentanediol is used as a key intermediate in the synthesis of various chemical compounds, particularly chelated multinuclear complexes. Its ability to form stable chelates with metal ions makes it a valuable component in the development of coordination compounds with potential applications in catalysis, pharmaceuticals, and materials science.
Used in the Pharmaceutical Industry:
In the pharmaceutical sector, 2,4-pentanediol is utilized as a building block for the synthesis of various drugs and drug candidates. Its hydroxyl groups can be easily modified to create a diverse array of molecules with specific biological activities, making it a versatile starting material for drug discovery and development.
Used in the Polymer Industry:
2,4-Pentanediol is also employed in the polymer industry as a monomer for the production of polyether and polyester polymers. These polymers find applications in a variety of fields, including automotive, electronics, and consumer goods, due to their excellent mechanical properties, chemical resistance, and thermal stability.
Used in the Cosmetics and Personal Care Industry:
In the cosmetics and personal care sector, 2,4-pentanediol is used as a solvent, emollient, and humectant. Its ability to dissolve a wide range of substances, as well as its moisturizing and humectant properties, make it a valuable ingredient in various cosmetic and personal care products, such as creams, lotions, and shampoos.
Used in the Food and Beverage Industry:
2,4-Pentanediol is also utilized in the food and beverage industry as a humectant, flavor enhancer, and preservative. Its ability to retain moisture and improve the texture of food products, as well as its compatibility with a wide range of flavors, makes it a useful additive in the production of various food and beverage items.

Safety Profile

Mildly toxic by ingestion and skin contact. Eye irritant. When heated to decomposition it emits acrid smoke and irritating fumes.

InChI:InChI=1/C5H12O2/c1-4(6)3-5(2)7/h4-7H,3H2,1-2H3/t4-,5-/m0/s1

Upstream product

• 917-64-6 methyl magnesium iodide 
• 107-89-1 acetaldol 
• 4161-60-8 4-hydroxypentan-2-one 
• 123-54-6 acetylacetone 
• 17615-19-9 3,4-pentadien-2-ol 
• 63315-69-5 (-)-(4R)-4-hydroxypentan-2-one 
• 22520-29-2 syn-3,4-epoxy-2-pentanol 
• 64-17-5 ethanol 
• 60-29-7 diethyl ether 
• 7732-18-5 water 
• 7664-93-9 sulfuric acid 
• 17227-17-7 2,2,4,6-tetramethyl-[1,3]dioxane 
• 56-81-5 glycerol 

Downstream Products

• 94309-72-5 2,4-bis-phenylcarbamoyloxy-pentane 
• 71671-14-2 C₁₉H₃₁NO₄ 
• 42075-35-4 4-(4r,6t-dimethyl-[1,3,2]dioxaborinan-2-yl)-benzoic acid 
• 7317-42-2 2,4-pentanediol phenylboronic ester 
• 34322-81-1 2-Phenoxy-4,6-dimethyl-1,3,2-dioxaborinan 
• 4727-93-9 4,6-dimethyltrimethylene (cis,cis) sulphite 
• 89238-89-1 (4R,6R)-4,6-Dimethyl-2-(4-nitro-phenyl)-[1,3]dioxane 
• 137626-21-2 rel-(2S,4R,6S)-4,6-dimethyl-2-(4'-nitrophenyl)-1,3-dioxane 
• 21589-60-6 (4R^*,6S^*)-4,6-Dimethyl-2-phenyl-1,3-dioxane 
• 130693-67-3 (2S^*,4R^*,6R^*)-4,6-Dimethyl-2-phenyl-1,3-dioxane 
• 4233-09-4 (2s*,4R*,6S*)-4,6-dimethyl-2-phenyl-1,3-dioxane 
• 123826-84-6 4-(benzyloxy)pentan-2-ol 
• 142572-25-6 2-N,N-Dimethylamino-cis-4,6-dimethyl-1,3-dioxane 
• 97996-52-6 (4R,6R)-2-Cyclohexyl-4,6-dimethyl-[1,3]dioxane 

Relevant academic research and scientific papers

Synthesis and Applications of (Pyridyl)imine Fe(II) Complexes as Catalysts in Transfer Hydrogenation of Ketones

Abstract: Chiral (pyridyl)imine Fe(II) complexes, [Fe(L1)3]2+[PF6?]2, (Fe1), [Fe(L2)3]2+[PF6?]2, (Fe2), [Fe(L3)3]2+[PF6?]2 (Fe3), and [Fe(L4)3]2+[PF6?]2 (Fe4) were synthesised by reactions of synthons (S-)-1-phenyl-N-(pyridine-2-yl) ethylidine)ethanamine (L1), (R-)-1-phenyl-N-(pyridine-2-yl) ethylidine) ethanamine (L2), (S)-1-phenyl-N-(pyridine-2-yl methylene) ethanamine (L3) and (S)-1-phenyl-N-(pyridine-2-yl methylene)ethanamine (L4) with the FeCl2 salt. The solid-state structure of complex Fe4 showed that the?Fe atom contains three units of bidentate bound ligand L4 to form a six-coordinate cationic compound. The Fe(II) complexes were evaluated as catalysts in asymmetric transfer hydrogenation of ketones reactions and showed moderate catalytic activities with low enantioselectivity. Catalytic activities of the respective complexes were regulated by the nature of the metal complexes, ketone substrate and reaction conditions. Mercury and sub-stoichiometric poisoning experiments implicate possible formation of both active Fe(0) nanoparticles and Fe(II) homogeneous intermediates. Graphic Abstract: [Figure not available: see fulltext.]

Method for preparing beta-diol from beta-diketone

The invention relates to a method for preparing beta-diol from beta-diketone. The method is characterized in that beta-diketone contacts and reacts with hydrogen in the presence of a hydrogenation catalyst under fixed bed reaction conditions, the hydrogenation catalyst comprises an active component copper and a carrier, and the hydrogenation catalyst preferably comprises an assistant component selected from VIIIB and IB group elements, the assistant is preferably selected from one or more of Ni, Co and Ag, and the carrier is SiO2. The method adopting a fixed bed hydrogenation technology and using a copper-containing supported catalyst has the advantages of no pollution to environment, mild operating conditions, and suitableness for continuous production.

Method for preparing beta-diol from beta-diketone by hydrogenation

The invention relates to a method for preparing beta-diol from beta-diketone by hydrogenation. The method comprises the following steps: in the presence of a catalyst and under the fixed-bed hydrotreating reaction condition, enabling beta-diketone to be in contact with hydrogen, so as to obtain beta-diol, wherein the catalyst contains CuO and ZnO, preferably also contains Al2O3, and more preferably also contains alkali metal oxides. According to the method for preparing beta-diol from beta-diketone by hydrogenation, provided by the invention, the technology of continuously producing beta-diol by adopting a fixed bed device is realized, the technology is simple and convenient to operate, the utilization ratio of raw materials and the production efficiency of products are improved, the reaction does not need to be carried out under high pressure, and potential safety hazards are reduced.

A β-diketone fixed bed hydrogenation method for preparing β-diol (by machine translation)

The invention relates to a β-diketone fixed bed hydrogenation method for preparing β-diol, including in the presence of hydrogenation catalyst under conditions and fixed bed reaction of the β-diketone reaction contact with hydrogen gas; the hydrogenation catalyst comprises active component copper and carrier, wherein in order to weight part, the content of copper is 20-35 parts, carrier is in a content of 60-80 parts. Preferably, the hydrogenation catalyst also includes selected from group IB and VIIIB additive component, more preferably the assistant is selected from Ni, Ag Co and in one or several of, the carrier is SiO 2. The method provided by the present invention which adopts a fixed bed hydrogenation process and the use of copper-containing supported catalyst, no pollution to the environment, mild operating conditions, is suitable for continuous production. (by machine translation)

Method for preparation of beta-diol

The present invention relates to a method for preparation of a beta-diol from a beta-diketone by hydrogenation, the method comprises contact reaction of the beta-diketone and hydrogen in the presence of a hydrogenation catalyst and under fixed bed reaction conditions, the hydrogenation catalyst is a non-noble metal catalyst, includes a metal component and a carrier, and can be prepared by a conventional method. The method uses a fixed bed hydrogenation process, and is free of environmental pollution, mild in operating conditions, and suitable for continuous production.

Rabbit 3-hydroxyhexobarbital dehydrogenase is a NADPH-preferring reductase with broad substrate specificity for ketosteroids, prostaglandin D2, and other endogenous and xenobiotic carbonyl compounds

3-Hydroxyhexobarbital dehydrogenase (3HBD) catalyzes NAD(P) +-linked oxidation of 3-hydroxyhexobarbital into 3-oxohexobarbital. The enzyme has been thought to act as a dehydrogenase for xenobiotic alcohols and some hydroxysteroids, but its physiological function remains unknown. We have purified rabbit 3HBD, isolated its cDNA, and examined its specificity for coenzymes and substrates, reaction directionality and tissue distribution. 3HBD is a member (AKR1C29) of the aldo-keto reductase (AKR) superfamily, and exhibited high preference for NADP(H) over NAD(H) at a physiological pH of 7.4. In the NADPH-linked reduction, 3HBD showed broad substrate specificity for a variety of quinones, ketones and aldehydes, including 3-, 17- and 20-ketosteroids and prostaglandin D2, which were converted to 3α-, 17β- and 20α-hydroxysteroids and 9α,11β- prostaglandin F2, respectively. Especially, α-diketones (such as isatin and diacetyl) and lipid peroxidation-derived aldehydes (such as 4-oxo- and 4-hydroxy-2-nonenals) were excellent substrates showing low Km values (0.1-5.9 μM). In 3HBD-overexpressed cells, 3-oxohexobarbital and 5β-androstan-3α-ol-17-one were metabolized into 3-hydroxyhexobarbital and 5β-androstane-3α,17β-diol, respectively, but the reverse reactions did not proceed. The overexpression of the enzyme in the cells decreased the cytotoxicity of 4-oxo-2-nonenal. The mRNA for 3HBD was ubiquitously expressed in rabbit tissues. The results suggest that 3HBD is an NADPH-preferring reductase, and plays roles in the metabolisms of steroids, prostaglandin D2, carbohydrates and xenobiotics, as well as a defense system, protecting against reactive carbonyl compounds.

An efficient one-step chemoselective reduction of alkyl ketones over aryl ketones in β-diketones using LiHMDS and lithium aluminium hydride

β-Hydroxy ketones were synthesized in one-pot from β-diketones by reducing alkyl ketones chemoselectively by keeping aryl ketone intact. Initially, β-diketones were enolized using LiHMDS and later alkyl ketone was chemoselectively reduced efficiently by lithium aluminium hydride. This method produces β- hydroxyl ketones from the corresponding β-diketones in high yield.

Albumin-directed stereoselective reduction of 1,3-diketones and β-hydroxyketones to anti diols

The reduction of 1,3-diketones and β-hydroxyketones with NaBH 4 in aqueous acetonitrile is highly stereoselective in the presence of stoichiometric amounts of bovine or human albumin, giving anti 1,3-diols with d.e. up to 96%. The same reaction, without albumin, gives syn and anti 1,3-diols in approximately 1:1 ratio. The presence of an aromatic carbonyl group is essential for diastereoselectivity in the NaBH4/albumin reduction of both 1,3-diketones and β-hydroxyketones. Thus, 3-hydroxy-1-(p-tolyl)-1- butanone is stereoselectively reduced in the presence of albumin, while reduction of its isomer 4-(p-tolyl)-4-hydroxy-2-butanone is not stereoselective. The albumin-controlled reduction is not stereospecific as both enantiomers of 1-aryl-3-hydroxy-1-butanones are reduced to diols with identical stereoselectivities. Circular dichroism of the bound substrates confirms that aromatic ketones are recognized by the protein's IIA binding site. Binding studies also suggest that 1,3-diketones are recognized in their enol form. From the effect of pH on binding of a diketone it is concluded that, in the complex with the substrate, ionizable residues His242 and Lys199 are in the neutral and protonated forms, respectively. A homology model of BSA was obtained and docking of model substrates confirms the preference of the protein for aromatic ketones. Modelling of the complexes with the substrates also allows us to propose a mechanism for the reduction of 1,3-diketones in which the chemoselective reduction of the first (aliphatic) carbonyl is followed by the diastereoselective reduction of the second (aromatic) carbonyl. The role of albumin is thus a combination of chemo- and stereocontrol.

Highly efficient and stereoselective biosynthesis of (2S,5S)-hexanediol with a dehydrogenase from Saccharomyces cerevisiae

The enantiopure (2S,5S)-hexanediol serves as a versatile building block for the production of various fine chemicals and pharmaceuticals. For industrial and commercial scale, the diol is currently obtained through bakers' yeast-mediated reduction of 2,5-hexanedione. However, this process suffers from its insufficient space-time yield of about 4 g L-1 d-1 (2S,5S)-hexanediol. Thus, a new synthesis route is required that allows for higher volumetric productivity. For this reason, the enzyme which is responsible for 2,5-hexanedione reduction in bakers' yeast was identified after purification to homogeneity and subsequent MALDI-TOF mass spectroscopy analysis. As a result, the dehydrogenase Gre2p was shown to be responsible for the majority of the diketone reduction, by comparison to a Gre2p deletion strain lacking activity towards 2,5-hexanedione. Bioreduction using the recombinant enzyme afforded the (2S,5S)-hexanediol with >99% conversion yield and in >99.9% de and ee. Moreover, the diol was obtained with an unsurpassed high volumetric productivity of 70 g L-1 d-1 (2S,5S)-hexanediol. Michaelis-Menten kinetic studies have shown that Gre2p is capable of catalysing both the reduction of 2,5-hexanedione as well as the oxidation of (2S,5S)-hexanediol, but the catalytic efficiency of the reduction is three times higher. Furthermore, the enzyme's ability to reduce other keto-compounds, including further diketones, was studied, revealing that the application can be extended to α-diketones and aldehydes.

Heterogenized Ru(II) phenanthroline complex for chemoselective hydrogenation of diketones under biphasic aqueous medium

The chemoselective hydrogenation of acetylacetone to 4-hydroxypentan-2-one over immobilized ruthenium phenanthroline metal complexes in amino functionalized MCM-41 in biphasic aqueous reaction medium was investigated. The catalyst was characterized by XRD, TEM, surface analysis, FT-IR and UV-vis to understand the morphology, complex geometry, and XPS such that the oxidation state of the metal complex inside the MCM-41 framework could be understood. The use of water as a solvent, not only gives high activity and selectivity for hydrogenation of acetylacetone, but also gives a path for an environmentally safer process. The optimizations of ligand, metal to ligand ratio, the choice of solvent and other reaction parameters were studied in detail. The heterogeneous catalytic system gave a higher degree of chemoselectivity (99%) towards 4-hydroxypentan-2-one as compared to homogeneous catalyst when hydrogenation was carried out using water as a solvent. The immobilized ruthenium-phenanthroline complex was easily separated and reused.